The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
Open accessAbstract
Gangliosides are the main glycolipids of neuronal plasma membranes. Their surface patterns are generated by coordinated processes, involving biosynthetic pathways of the secretory compartments, catabolic steps of the endolysosomal system, and intracellular trafficking. Inherited defects in ganglioside biosynthesis causing fatal neurodegenerative diseases have been described so far almost exclusively in mouse models, whereas inherited defects in ganglioside catabolism causing various clinical forms of GM1- and GM2-gangliosidoses have long been known. For digestion, gangliosides are endocytosed and reach intra-endosomal vesicles. At the level of late endosomes, they are depleted of membrane-stabilizing lipids like cholesterol and enriched with bis(monoacylglycero)phosphate (BMP). Lysosomal catabolism is catalyzed at acidic pH values by cationic sphingolipid activator proteins (SAPs), presenting lipids to their respective hydrolases, electrostatically attracted to the negatively charged surface of the luminal BMP-rich vesicles. Various inherited defects of ganglioside hydrolases, e.g., of β-galactosidase and β-hexosaminidases, and of GM2-activator protein, cause infantile (with tetraparesis, dementia, blindness) and different protracted clinical forms of GM1- and GM2-gangliosidoses. Mutations yielding proteins with small residual catabolic activities in the lysosome give rise to juvenile and adult clinical forms with a wide range of clinical symptomatology. Apart from patients' differences in their genetic background, clinical heterogeneity may be caused by rather diverse substrate specificities and functions of lysosomal hydrolases, multifunctional properties of SAPs, and the strong regulation of ganglioside catabolism by membrane lipids. Currently, there is no treatment available for neuronal ganglioside storage diseases. Therapeutic approaches in mouse models and patients with juvenile forms of gangliosidoses are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Molecular mechanism of multivesicular body biogenesis by ESCRT complexes
Wollert, T., & Hurley, J. H. (2010) · Nature · doi:10.1038/nature08849 · Cited by 804
Kwon, H. J., Abi-Mosleh, L., Wang, M. L., Deisenhofer, J., Goldstein, J. L., Brown, M. S., & Infante, R. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.049 · Cited by 636
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Kannagi, R., Cochran, N. A., Ishigami, F., Hakomori, S., Andrews, P. W., Knowles, B. B., & Solter, D. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01746.x · Cited by 545
Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519
Self-citationA vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Self-citationSango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468
Self-citationKolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464
Self-citationSpecific interaction between Lex and Lex Determinants
Eggens, I., Fenderson, B., Toyokuni, T., Dean, B., Stroud, M., & Hakomori, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60556-3 · Cited by 450
Generalized Gangliosidosis: Beta-Galactosidase Deficiency
Okada, S., & O'Brien, J. S. (1968) · Science · doi:10.1126/science.160.3831.1002 · Cited by 428
Structures, Biosynthesis, and Functions of Gangliosides-an Overview
Yu, R. K., Tsai, Y.-T., Ariga, T., & Yanagisawa, M. (2011) · Journal of Oleo Science · doi:10.5650/jos.60.537 · Cited by 416
Wada, R., Tifft, C. J., & Proia, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10954 · Cited by 403
Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1460 · Cited by 389
Sphingolipids—Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases
Kolter, T., & Sandhoff, K. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1532::aid-anie1532>3.0.co;2-u · Cited by 386
Self-citationCommon and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
Vitner, E. B., Platt, F. M., & Futerman, A. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.134452 · Cited by 369
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Self-citationNeuronal ceroid lipofuscinoses
Jalanko, A., & Braulke, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.004 · Cited by 339
Leinekugel, P., Michel, S., Conzelmann, E., & Sandhoff, K. (1992) · Human Genetics · doi:10.1007/bf00219337 · Cited by 327
Self-citationCombinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Self-citationDie Konstitution der Ganglio‐N‐tetraose und des Gangliosids GI
Kuhn, R., & Wiegandt, H. (1963) · Chemische Berichte · doi:10.1002/cber.19630960329 · Cited by 293
Eine Cerebrosidsulfatase aus Schweineniere
Mehl, E., & Jatzkewitz, H. (1964) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1964.339.1.260 · Cited by 279
Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease
Purpura, D. P., & Suzuki, K. (1976) · Brain Research · doi:10.1016/0006-8993(76)90245-6 · Cited by 277
Lysosomal degradation of membrane lipids
Kolter, T., & Sandhoff, K. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.021 · Cited by 275
Self-citationPartial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders
Conzelmann, E., & Sandhoff, K. (2009) · Developmental Neuroscience · doi:10.1159/000112332 · Cited by 272
Self-citationChemical chaperone therapy for brain pathology in G M1 -gangliosidosis
Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K., Itoh, M., Matsuzaki, Y., Yasuda, Y., Ogawa, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536657100 · Cited by 262
Progressive Accumulation of Toxic Metabolite in a Genetic Leukodystrophy
Igisu, H., & Suzuki, K. (1984) · Science · doi:10.1126/science.6719111 · Cited by 236
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Self-citationTessitore, A., del P. Martin, M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E. D., Steindler, D. A., Hendershot, L. M., & d'Azzo, A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.029 · Cited by 225
Kytzia, H. J., & Sandhoff, K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39645-x · Cited by 220
Self-citationImino sugar inhibitors for treating the lysosomal glycosphingolipidoses
Butters, T. D., Dwek, R. A., & Platt, F. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi076 · Cited by 218
Klenk, E. (1939) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1939.262.3-5.128 · Cited by 214
Sango, K., McDonald, M. P., Crawley, J. N., Mack, M. L., Tifft, C. J., Skop, E., Starr, C. M., Hoffmann, A., Sandhoff, K., Suzuki, K., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-348 · Cited by 201
Self-citationTropak, M. B., Reid, S. P., Guiral, M., Withers, S. G., & Mahuran, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308523200 · Cited by 197
Lemieux, M. J., Mark, B. L., Cherney, M. M., Withers, S. G., Mahuran, D. J., & James, M. N. G. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.004 · Cited by 193
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Self-citationOkada, M., Itoh, M.-I., Haraguchi, M., Okajima, T., Inoue, M., Oishi, H., Matsuda, Y., Iwamoto, T., Kawano, T., Fukumoto, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100395200 · Cited by 179 · cited 1×
“Mutant mice defective in b-series gangliosides were viable and without apparent neurological abnormalities (Kawai et al., 2001; Okada et al., 2002) and reach an almost normal life span.”
Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jäger, R., Schorle, H., Kenzelmann, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500893102 · Cited by 178
Myerowitz, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1343 · Cited by 173
Lysosomal Degradation on Vesicular Membrane Surfaces
Wilkening, G., Linke, T. A., & Sandhoff, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30271 · Cited by 172
Self-citationBrain gangliosides in axon–myelin stability and axon regeneration
Schnaar, R. L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.011 · Cited by 169
Multi-system disorders of glycosphingolipid and ganglioside metabolism
Xu, Y.-H., Barnes, S., Sun, Y., & Grabowski, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r003996 · Cited by 166
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
Cachón-González, M. B., Wang, S. Z., Lynch, A. G., Ziegler, R. J., Cheng, S. H., & Cox, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603765103 · Cited by 161
Sphingolipid Activator Proteins Are Required for Epidermal Permeability Barrier Formation
Doering, T., Holleran, W. M., Potratz, A., Vielhaber, G., Elias, P. M., Suzuki, K., & Sandhoff, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11038 · Cited by 153
Self-citationAutophagy proteins in macroendocytic engulfment
Florey, O., & Overholtzer, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.005 · Cited by 150
Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy.
Stevens, R. L., Fluharty, A. L., Kihara, H., Kaback, M. M., Shapiro, L. J., Marsh, B. R., Sandhoff, K., & Fischer, G. (1981) · PubMed · Cited by 141
Self-citationInterfacial Regulation of Acid Ceramidase Activity
Linke, T. A., Wilkening, G., Sadeghlar, F., Mozcall, H., Bernardo, K., Schuchman, E. H., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006846200 · Cited by 139
Self-citationGallala, H. D., & Sandhoff, K. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0337-6 · Cited by 137
Self-citationRefractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency
Fragaki, K., Ait-El-Mkadem, S., Chaussenot, A., Gire, C., Mengual, R., Bonesso, L., Bénéteau, M., Ricci, J., Desquiret‐Dumas, V., Procaccio, V., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.202 · Cited by 132
Lysosomal multienzyme complex: Biochemistry, genetics, and molecular pathophysiology
Pshezhetsky, A. V., & Ashmarina, M. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69045-7 · Cited by 131 · cited 1×
“The nonspecific and versatile GM1 degrading -galactosidase occurs as part of a lysosomal multi-enzyme complex, containing sialidase, cathepsin A (the so-called protective protein) (d’Azzo et al., 2001), and N-acetylaminogalacto-6-sulfate sulfatase (Pshezhetsky and Ashmarina, 2001).”
Clarke, J. T. R., Mahuran, D. J., Sathe, S. A., Kolodny, E. H., Rigat, B. A., Raiman, J., & Tropak, M. B. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.09.004 · Cited by 123
NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycin
Jeyakumar, M., Smith, D. A., Williams, I. M., Cortina‐Borja, M., Neville, D. C. A., Butters, T. D., Dwek, R. A., & Platt, F. M. (2004) · Annals of Neurology · doi:10.1002/ana.20242 · Cited by 122
Integrity and Barrier Function of the Epidermis Critically Depend on Glucosylceramide Synthesis
Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H. D., Sandhoff, K., Wiegandt, H., & Gröne, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610304200 · Cited by 117
Self-citationThe X-ray Crystal Structure of Human β-Hexosaminidase B Provides New Insights into Sandhoff Disease
Maier, T., Sträter, N., Schuette, C. G., Klingenstein, R., Sandhoff, K., & Saenger, W. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00311-5 · Cited by 117
Self-citationExtracellular matrix, cell skeletons, and embryonic development
Hay, E. D. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320340107 · Cited by 115
Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content
Appelqvist, H., Sandin, L., Björnström, K., Saftig, P., Garner, B., Öllinger, K., & Kågedal, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050262 · Cited by 108 · cited 1×
“Perimeter membranes are protected by a thick glycocalyx enriched in polylactosamine structures, and by a high cholesterol level (Hay, 1989; Appelqvist et al., 2012), the chaperon HSP70 (Kirkegaard et al., 2010), and presumably also by a high lateral pressure attenuating the interaction with GM2AP,…”
Degradation of Membrane-bound Ganglioside GM1
Wilkening, G., Linke, T. A., Uhlhorn-Dierks, G., & Sandhoff, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006568200 · Cited by 108
Self-citationKeilani, S., Lun, Y., Stevens, A. C., Williams, H. N., Sjoberg, E. R., Khanna, R., Valenzano, K. J., Checler, F., Buxbaum, J. D., Yanagisawa, K., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4860-11.2012 · Cited by 105
Tamboli, I. Y., Hampel, H., Tien, N. T., Tolksdorf, K., Breiden, B., Mathews, P. M., Säftig, P., Sandhoff, K., & Walter, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2954-10.2011 · Cited by 98
Self-citationCharacterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids.
Li, S. C., Sonnino, S., Tettamanti, G., & Li, Y. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68681-8 · Cited by 92
Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis
Tsuji, D., Akeboshi, H., Matsuoka, K., Yasuoka, H., Miyasaki, E., Kasahara, Y., Kawashima, I., Chiba, Y., Jigami, Y., Taki, T., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22262 · Cited by 92
Nilsson, O., Månsson, J., Håk̈ansson, G., & Svennerholm, L. T. (1982) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(82)90272-7 · Cited by 91
Baek, R. C., Broekman, M. L. D., LeRoy, S. G., Tierney, L. A., Sandberg, M. A., d’Azzo, A., Seyfried, T. N., & Sena‐Esteves, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013468 · Cited by 90
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 85
Structural Analysis of Lipid Complexes of GM2-Activator Protein
Wright, C. S., Zhao, Q., & Rastinejad, F. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00794-0 · Cited by 84
Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion
Abdul-Hammed, M., Breiden, B., Adebayo, M. A., Babalola, J. O., Schwarzmann, G. O. H., & Sandhoff, K. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003822 · Cited by 84
Self-citationBroekman, M. L. D., Baek, R. C., Comer, L. A., Fernandez, J. L., Seyfried, T. N., & Sena‐Esteves, M. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300004 · Cited by 83
Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease
Taniike, M., Yamanaka, S., Proia, R. L., Langaman, C., Bone-Turrentine, T., & Suzuki, K. (1995) · Acta Neuropathologica · doi:10.1007/bf00309622 · Cited by 82
Andersson-Hall, U. K., Smith, D. A., Jeyakumar, M., Butters, T. D., Cortina‐Borja, M., Dwek, R. A., & Platt, F. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.012 · Cited by 81
Giehl, A., Lemm, T., Bartelsen, O., Sandhoff, K., & Blume, A. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00302.x · Cited by 76
Self-citationGraber, D., Salvayre, R., & Levade, T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63031060.x · Cited by 76
Martino, S., Marconi, P., Tancini, B., Dolcetta, D., Angelis, M. G. C. D., Montanucci, P., Bregola, G., Sandhoff, K., Bordignon, C., Emiliani, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi216 · Cited by 75
Self-citationMöbius, W., Herzog, V., Sandhoff, K., & Schwarzmann, G. O. H. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700804 · Cited by 74
Self-citationDegradation of Membrane-bound Ganglioside GM2 by β-Hexosaminidase A
Werth, N., Schuette, C. G., Wilkening, G., Lemm, T., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007970200 · Cited by 72
Self-citationDeficient Ganglioside Biosynthesis: A Novel Human Sphingolipidosis
Fishman, P. H., Max, S. R., Tallman, J. F., Brady, R. O., Maclaren, N. K., & Cornblath, M. (1975) · Science · doi:10.1126/science.803227 · Cited by 56
Jk, B., Hüttler, S., Klein, A., Möbius, W., Habermann, A., Griffiths, G., & Sandhoff, K. (1997) · PubMed · Cited by 54
Self-citationPhotoaffinity labelling of the Human GM2‐activator protein
Wendeler, M., Hoernschemeyer, J., Hoffmann, D. E., Kolter, T., Schwarzmann, G., & Sandhoff, K. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2003.03964.x · Cited by 53
Self-citationRegulation of the NPC2 protein‐mediated cholesterol trafficking by membrane lipids
Gallala, H. D., Breiden, B., & Sandhoff, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07014.x · Cited by 51
Self-citationBiochemical Basis of Late-Onset Neurolipidoses
Conzelmann, E., & Sandhoff, K. (1991) · Developmental Neuroscience · doi:10.1159/000112160 · Cited by 51
Self-citationActivator protein for the degradation of globotriaosylceramide by human alpha-galactosidase.
Gärtner, S., Conzelmann, E., & Sandhoff, K. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44186-x · Cited by 49
Self-citationHepatic Glycosphingolipid Deficiency and Liver Function in Mice
Jennemann, R., Rothermel, U., Wang, S., Sandhoff, R., Kaden, S., Out, R., van Berkel, T. J. C., Aerts, J. M. F. G., der Vlugt, K. G., Sticht, C., et al. (2010) · Hepatology · doi:10.1002/hep.23545 · Cited by 48
My journey into the world of sphingolipids and sphingolipidoses
Sandhoff, K. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.554 · Cited by 42
Self-citationBourgoin, C., Emiliani, C., Kremer, E. J., Gélot, A., Tancini, B., Gravel, R. A., Drugan, C., Orlacchio, A., Poënaru, L., & Caillaud, C. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302081 · Cited by 41
Gene Therapy of Storage Disorders by Retroviral and Lentiviral Vectors
Biffi, A., & Naldini, L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1133 · Cited by 39
Imbalanced substrate specificity of mutant β-galactosidase in patients with Morquio B disease
Okumiya, T., Sakuraba, H., Kase, R., & Sugiura, T. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00199-3 · Cited by 37
Arfı, A., Bourgoin, C., Basso, L., Emiliani, C., Tancini, B., Chigorno, V., Li, Y., Orlacchio, A., Poënaru, L., Sonnino, S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.017 · Cited by 36
A particle-bound sialyl lactosidoceramide splitting mammalian sialidase
Sandhoff, K., & Jatzkewitz, H. (1967) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(67)90124-9 · Cited by 32
Self-citationCritical role of iron in the pathogenesis of the murine gangliosidoses
Jeyakumar, M., Williams, I. M., Smith, D. A. B., Cox, T. M., & Platt, F. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.015 · Cited by 31
The Biochemistry of Sphingolipid Storage Diseases
Sandhoff, K. (1977) · Angewandte Chemie International Edition in English · doi:10.1002/anie.197702733 · Cited by 31
Self-citationTreatment options for lysosomal storage disorders: developing insights
Gelder, C. M. V., Vollebregt, A. A. M., Plug, I., van der Ploeg, A. T., & Reuser, A. J. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.729039 · Cited by 28
Fantur, K., Wrodnigg, T. M., Stütz, A., Pabst, B. M., & Paschke, E. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9409-2 · Cited by 27
Kytzia, H., HINRICHS, U., & Sandhoff, K. (1984) · Human Genetics · doi:10.1007/bf00291402 · Cited by 27
Self-citationWendeler, M., Hoernschemeyer, J., John, M., Werth, N., Schoeniger, M., Lemm, T., Hartmann, R., Kessler, H., & Sandhoff, K. (2003) · Protein Expression and Purification · doi:10.1016/j.pep.2003.11.010 · Cited by 25
Self-citationBiomolecule Function: No Reliable Prediction from Cell Culture
Kolter, T., Magin, T. M., & Sandhoff, K. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.011007.x · Cited by 24
Self-citationCharacterization of Inducible Models of Tay-Sachs and Related Disease
Sargeant, T. J., Drage, D., Wang, S., Apostolakis, A. A., Cox, T. M., & Cachón-González, M. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002943 · Cited by 21
Glykolipide der Zelloberfl�che ? Biochemie ihres Abbaus
Sandhoff, K., & Kolter, T. (1995) · Die Naturwissenschaften · doi:10.1007/bf01133673 · Cited by 17
Self-citation
Cited by
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Virus–Receptor Interactions: The Key to Cellular Invasion
Maginnis, M. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.024 · Cited by 413
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403
Metadata
- Authors
- Sandhoff, K., & Harzer, K.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2013-06-19
- Volume
- 33
- Issue
- 25
- Pages
- 10195-10208
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2055898352
- Cited by
- 280
- References
- 97
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.